Lifeline Biotechnologies Updates Info for Pink Sheets

Lifeline Biotechnologies, Inc. has announced that it has completed the updating of the Company's information on Pinks Sheets.

Jim Holmes, Lifeline's CEO, said, "The 'Stop Sign' on our Company site at Pink Sheets has been removed. The information filed with Pinks Sheets this past week was sufficient to remove the 'Stop Sign'. The information submitted includes a Balance Sheet, Statement of Operations and Outstanding Common Shares as of June 30.

"We have had questions on our current FDA filing. We await the FDA's response, which could be received as early as the end of September. However, that is probably optimistic and it could be some additional 30 to 45 days before we receive the FDA's response. As soon as we have the response we expect to release the information to the public.

"We've also received many questions concerning the prospect of a reverse split of the common stock. We have no plans to reverse split Lifeline's common stock."

More Information:

www.pinksheets.com

((Comments on this story may be sent to health@closeupmedia.com))

Related terms: ceo, fda, health